| 摘要 |
<p>The present disclosure concerns the field of diagnostic biological markers. Specifically the disclosure relates to anti-BAG3 antibodies for use as biological markers for the diagnosis of a pathological state. Furthermore, the disclosure involves specific ELISA methods and kits, for detecting and evaluating, anti-BAG3 antibodies or BAG3/antibody complexes in a biological sample.</p> |
